- 1) Trauth, B. C., Klas, C., Peters, A. M., Matzku, S., Moller, P., Falk, W., Debatin, K. M., and Krammer, P. H., Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science, 245, 301-305 (1989).
- 2) Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y., and Nagata, S., The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell, 66, 233-243 (1991).
- 3) Suda, T., Takahashi, T., Golstein, P., and Nagata, S., Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell, 75, 1169-1178 (1993).
- 4) Watanabe-Fukunaga, R., Brandon, C. I., Yonehara, S., Cropland, N. G., Jerkins, N. A., and Nagata, S., The structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol., 148, 1274-1279 (1992).
- 5) Hoa, T. T. M., Hasunuma, T., Aono, H., Masuko, K., Kobata, T., Yamamoto, K., Sumida, T., and Nishioka, K., Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis. J. Rheumatol., 23, 1332-1337 (1996).
- 6) Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., and Nagata, S., Lethal effect of the anti-Fas antibody in mice. Nature, 364, 806-809 (1993).
- 7) Dhein, J., Walczak, H., Westendorp, M. O., Baumler, C., Stricker, K., Frank, R., Debatin, K. M., and Krammer, P. H., Molecular mechanisms of APO-1/Fas (CD95)-mediated apoptosis in tolerance and AIDS. Behring. Inst. Mitt., 96, 13-20 (1995).
- 8) McCloskey, T. W., Oyaizu, N., Kaplan, M., and Pahwa, S., Expression of the Fas antigen in patients infected with human immunodeficiency virus. Cytometry, 22, 111-114 (1995).
- 9) Owen-Schaub, L. B., Yonehara, S., Crump, W. L., and Grimm, E. A., DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol., 140, 197-205 (1992).
- 10) Chu, J. L., Ramos, P., Rosendorff, A., Nikolic-Zugic, J., Lacy, E., Matsuzawa, A., and Elkon, K. B., Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome. J. Exp. Med., 181, 393-398 (1995).
- 11) Tanaka, M., Itai, T., Adachi, M., and Nagata, S., Downregulation of Fas ligand by shedding. Nature Med., 4, 31-36 (1998).
- 12) Tanaka, M., Suda, T., Yatomi, T., Makamura, N., and Nagata, S., Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes. J. Immunol., 158, 2303-2309 (1997).
- 13) Nakajima, T., Aono, H., Hasunuma, T., Yamamoto, K., Shirai, T., Hirohata, K., and Nishioka, K., Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis-Rheum., 38, 485-491 (1995).
- 14) Firestein, G. S., Yeo, M., and Zvaifler, N. J., Apoptosis in rheumatoid arthritis synovium. J. Clin. Invest., 96, 1631-1638 (1995).
- 15) Sakai, K., Matsuno, H., Morita, I., Nezuka, T., Tsuji, H., Shirai, T., Yonehara, S., Hasunuma, T., and Nishioka, K., Potential withdrawal of rheumatoid synovium by the induction of apoptosis using a novel in vivo model of rheumatoid arthritis. Arthritis Rheum., 41, 1251-1257 (1998).
- 16) Nishimura-Morita, Y., Nose, M., Inoue, T., and Yonehara, S., Amelioration of systemic autoimmune disease by the stimulation of apoptosis-promoting receptor Fas with anti-Fas mAb. Int. Immunol., 9, 1793-1799 (1997).
- 17) Ichikawa, K., Yoshida-Kato, H., Ohtsuki, M., Ohsumi, J., Yamaguchi, J., Takahashi, S., Tani, Y., Watanabe, M., Shiraishi, A., Nishioka, K., Yonehara, S., and Serizawa, N., A novel murine anti-human Fas monoclonal antibody which mitigates lymphadenopathy without hepatotoxicity. Int. Immunol., 12, 555-562 (2000).
- . 1991.
Bioscience, Biotechnology, and Biochemistry
Volume 64, 2000 - Issue 9